PTGX FY 2019 Earnings — Protagonist Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTGXProtagonist Therapeutics, Inc.

$6B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$231,000-99.3% YoY

Gross Profit

$231,000100.0% margin

Operating Income

-$81M-34857.6% margin

Net Income

-$77M-33414.3% margin

EPS (Diluted)

$-2.98

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$42M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$155M

Total Liabilities

$75M

Stockholders' Equity

$80M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$231,000	$31M	-99.3%
Gross Profit	$231,000	$31M	-99.3%
Operating Income	-$81M	-$42M	-90.5%
Net Income	-$77M	-$39M	-98.3%